Lenalidomide and Ceftazidime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lenalidomide (lenalidomide) and Ceftazidime (ceftazidime). Common drug interactions include neutropenia among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Lenalidomide and Ceftazidime. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

On Jul, 15, 2026

44 people who take Lenalidomide and Ceftazidime together, and have interactions are studied.

Lenalidomide and Ceftazidime drug interactions.

What are the common drug interactions of Lenalidomide and Ceftazidime, by gender? *:

female:

Neutropenia (an abnormally low number of neutrophils)
Pyrexia (fever)
Confusional state
Pseudomonal sepsis (pseudomonas infections are diseases caused by a bacterium from the genus pseudomonas)
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
C-reactive protein increased
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Glomerular filtration rate decreased
Immunosuppression

male:

Febrile neutropenia (fever with reduced white blood cells)
Thrombocytopenia (decrease of platelets in blood)
Loss of consciousness
Pneumonia
Intestinal obstruction
Overdose
Diarrhoea
Drug ineffective
Encephalopathy (functioning of the brain is affected by some agent or condition)
Hodgkin's disease (cancer originating from white blood cells)

What are the common drug interactions of Lenalidomide and Ceftazidime, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal distension
Anuria (failure of the kidneys to produce urine)
Kidney enlargement
Pneumonia
Respiratory tract infection
Thrombosis (formation of a blood clot inside a blood vessel)
Ureteric dilatation
Influenza like illness

50-59:

Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Febrile neutropenia (fever with reduced white blood cells)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Hyperglycaemia (high blood sugar)
Hypotension (abnormally low blood pressure)
Pseudomonal sepsis (pseudomonas infections are diseases caused by a bacterium from the genus pseudomonas)
Septic shock (shock due to blood infection)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
Thrombocytopenia (decrease of platelets in blood)

60+:

Pyrexia (fever)
Neutropenia (an abnormally low number of neutrophils)
Glomerular filtration rate decreased
Immunosuppression
Intestinal obstruction
Leukopenia (less number of white blood cells in blood)
Macrophages increased (increased immune cells that eats foreign material and dead cells)
Thrombocytopenia (decrease of platelets in blood)
Diarrhoea
Hodgkin's disease (cancer originating from white blood cells)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 18 people, 40.91%
Fever: 10 people, 22.73%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 9 people, 20.45%
Diarrhea: 7 people, 15.91%
Burkitt Lymphoma (cancer of the lymphatic system): 6 people, 13.64%
Diabetes: 6 people, 13.64%
Febrile Neutropenia (fever with reduced white blood cells): 6 people, 13.64%
Hypokalemia (low potassium): 6 people, 13.64%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 6 people, 13.64%
Oedema Peripheral (superficial swelling): 5 people, 11.36%

* Approximation only. Some reports may have incomplete information.

Do you take Lenalidomide and Ceftazidime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously